video: Moderated & Public Q&A with MS Neurologists Boster and LaGanke
Event date: July 26, 2025 Moderator: Stuart Schlossman, President of MS Views and News / MS Patient Advocate At the…
Categories
Latest Blog Posts
- Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU (European Union) as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
- FDA clears CTA313 (Car-T Cellular Therapy) trial for progressive MS, autoimmune disease
- Multiple Sclerosis or Lupus: Can You Have Both?
- What to Know About the Link Between Multiple Sclerosis and Psoriatic Arthritis
- Is an MS Flare-Up the Same as a Relapse?
- Going Gluten-Free for MS? Here Are 5 Easy Recipes
- Blood Proteins Identified That Predict Multiple Sclerosis Early
- How to Have a Healthy Sex Life When You Have Multiple Sclerosis
- New anatomy of the clitoris and its implications for women with MS and their partners
- I Feel Like I Have MS Today ( a patient’s story)
- Is there a link between MS and Alzheimer’s (AD)
- What is Cog Fog (Cognitive or Brain Fog) and How to Deal with This Frequent MS Symptom
- Understanding the Genetics of Multiple Sclerosis
- CMSC 2026: Trial data show frexalimab benefits lasting 3 years
- Sedentary behavior and its correlates in adults with multiple sclerosis
- Key multiple sclerosis models reveal different damage timelines, offering roadmap for myelin repair studies
- Avoid These 7 Foods That Accelerate Aging
- AI Regulation & Transparency in Radiology with Dr. Hugh Harvey (ECR25)
- Genetic Maps Target Root Causes of Multiple Sclerosis
- Why Mantras Could Help Ease Depression — Plus, 7 Sample Mantras to Try
